J0175 Injection, donanemab-azbt, 2 mg

Billable / valid for submission HCPCS Release 2026Q3

Short description: Inj, donanemab-azbt, 2 mg

Version history

Related codes in J01

• J0120 Injection, tetracycline, up to 250 mg
• J0121 Injection, omadacycline, 1 mg
• J0122 Injection, eravacycline, 1 mg
• J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J0130 Injection abciximab, 10 mg
• J0131 Injection, acetaminophen, not otherwise specified,10 mg
• J0132 Injection, acetylcysteine, 100 mg
• J0133 Injection, acyclovir, 5 mg
• J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg
• J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg
• J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg
• J0138 Injection, acetaminophen 10 mg and ibuprofen 3 mg
• J0139 Injection, adalimumab, 1 mg
• J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
• J0162 Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg
• J0163 Injection, epinephrine in sodium chloride (endo), 0.1 mg
• J0164 Injection, epinephrine in sodium chloride (baxter), 0.1 mg
• J0165 Injection, epinephrine, not otherwise specified, 0.1 mg
• J0166 Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg
• J0167 Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg

All J01 codes →